1.
Hindsø M, Martinussen C, Svane MS, Veedfald S, Gade-Rasmussen B, Hansen T, et al. Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes. EJCRIM [Internet]. 2021 Mar. 31 [cited 2026 Nov. 3];8(3). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2352